274
Views
36
CrossRef citations to date
0
Altmetric
Perspectives

Lyme disease: the next decade

&
Pages 1-9 | Published online: 07 Jan 2011

References

  • StrickerRBLautinABurrascanoJJLyme disease: point/counterpointExpert Rev Anti-Infect Ther2005315516515918774
  • HarveyWTSalvatoP‘Lyme disease’: ancient engine of an unrecognized borreliosis pandemic?Med Hypotheses20036074275912710914
  • WormserGPDattwylerRJShapiroEDThe clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of AmericaClin Infect Dis2006431089113417029130
  • IDSA WebsiteFrequently asked questions about Lyme disease Available from: http://www.idsociety.org/lymediseasefacts.htm. Accessed Nov 8 2010.
  • CameronDGaitoAHarrisNEvidence-based guidelines for the management of Lyme diseaseExpert Rev Anti Infect Ther20042Suppl 1S1S1315581390
  • Connecticut Attorney General’s OfficeAttorney General’s investigation reveals flawed Lyme disease guideline process, IDSA agrees to reassess guidelines, install independent arbiter200851 Available from: http://www.ct.gov/ag/cwp/view.asp?a=2795&q=414284. Accessed Nov 8 2010.
  • StrickerRBJohnsonLThe Infectious Diseases Society of America Lyme guidelines: poster child for guidelines reformSouth Med J200910256556619434025
  • JohnsonLStrickerRBThe Infectious Diseases Society of America Lyme guidelines: a cautionary tale about development of clinical practice guidelinesPhilos Ethics Humanit Med20105920529367
  • JohnsonLStrickerRBFinal report of the Lyme Disease Review Panel of the Infectious Diseases Society of America: A pyrrhic victory?Clin Infect Dis2010511108110920925511
  • CasjensSPalmerNvan VugtRA bacterial genome in flux: the twelve linear and nine circular extrachromosomal DNAs in an infectious isolate of the Lyme disease spirochete Borrelia burgdorferiMol Microbiol20003549051610672174
  • Von LackumKBabbKRileySPWattierRLBykowskiTStevensonBFunctionality of Borrelia burgdorferi LuxS: the Lyme disease spirochete produces and responds to the pheromone autoinducer-2 and lacks a complete activated-methyl cycleInt J Med Microbiol2006296Suppl 409210216530477
  • BulutYFaureEThomasLEquilsOArditiMCooperation of Toll-like receptor 2 and 6 for cellular activation by soluble tuberculosis factor and Borrelia burgdorferi outer surface protein A lipoprotein: role of Toll-interacting protein and IL-1 receptor signaling molecules in Toll-like receptor 2 signalingJ Immunol200116798799411441107
  • EmbersMERamamoorthyRPhilippMTSurvival strategies of Borrelia burgdorferi, the etiologic agent of Lyme diseaseMicrobes Infect2004631231815065567
  • SkotarczakBAdaptation factors of Borrelia for host and vectorAnn Agric Environ Med2009161819572471
  • CruzARMooreMWLa VakeCJEggersCHSalazarJCRadolfJDPhagocytosis of Borrelia burgdorferi, the Lyme disease spirochete, potentiates innate immune activation and induces apoptosis in human monocytesInfect Immun200876567017938216
  • PietikainenJMeriTBlomAMMeriSBinding of the complement inhibitor C4b-binding protein to Lyme disease BorreliaeMol Immunol2010471299130520022381
  • LovrichSDCallisterSMSchmitzJLAlderJDSchellRFBorreliacidal activity of sera from hamsters infected with the Lyme disease spirocheteInfect Immun199159252225281855973
  • MontgomeryRRNathansonMHMalawistaSEThe fate of Borrelia burgdorferi, the agent for Lyme disease, in mouse macrophages. Destruction, survival, recoveryJ Immunol19931509099158423346
  • MalawistaSEBartholdSWPersingDHFate of Borrelia burgdorferi DNA in tissues of infected mice after antibiotic treatmentJ Infect Dis1994170131213167963735
  • BockenstedtLKMaoJHodzicEBartholdSWFishDDetection of attenuated, noninfectious spirochetes in Borrelia burgdorferi-infected mice after antibiotic treatmentJ Infect Dis20021861430143712404158
  • YrjänäinenHHytönenJSongXYOksiJHartialaKViljanenMKAnti-tumor necrosis factor-alpha treatment activates Borrelia burgdorferi spirochetes 4 weeks after ceftriaxone treatment in C3H/He miceJ Infect Dis20071951489149617436229
  • HodzicEFengSHoldenKFreetKJBartholdSWPersistence of Borrelia burgdorferi following antibiotic treatment in miceAntimicrob Agents Chemother2008521728173618316520
  • BartholdSWHodzicEImaiDMFengSYangXLuftBJIneffectiveness of tigecycline against persistent Borrelia burgdorferiAntimicrob Agents Chemother201054643645119995919
  • YrjänäinenHHytönenJHartialaPOksiJViljanenMKPersistence of borrelial DNA in the joints of Borrelia burgdorferi-infected mice after ceftriaxone treatmentAPMIS2010118665667320718718
  • StraubingerRKSummersBAChangYFAppelMJPersistence of Borrelia burgdorferi in experimentally infected dogs after antibiotic treatmentJ Clin Microbiol1997351111168968890
  • StraubingerRKPCR-based quantification of Borrelia burgdorferi organisms in canine tissues over a 500-day postinfection periodJ Clin Microbiol2000382191219910834975
  • ChangYFKuYWChangCFAntibiotic treatment of experimentally Borrelia burgdorferi-infected poniesVet Microbiol200510728529415863289
  • Preac-MursicVPatsourisEWilskeBReinhardtSGrossBMehraeinPPersistence of Borrelia burgdorferi and histopathological alterations in experimentally infected animals. A comparison with histopathological findings in human Lyme diseaseInfection1990183323412076905
  • CadavidDBaiYHodzicENarayanKBar tholdSWPachnerARCardiac involvement in non-human primates infected with the Lyme disease spirochete Borrelia burgdorferiLab Invest2004841439145015448708
  • MillerJCNarayanKStevensonBPachnerARExpression of Borrelia burgdorferi erp genes during infection of non-human primatesMicrob Pathog200539273315964737
  • PhillipsSEHarrisNSHorowitzRJohnsonLStrickerRBLyme disease: scratching the surfaceLancet2005366177116298211
  • PhillipsSEBurrascanoJJHarrisNSJohnsonLSmithPVStrickerRBChronic infection in ‘post-Lyme borreliosis syndrome’Int J Epidemiol2005341439144016319107
  • SteereACFalkBDrouinEEBaxter-LoweLAHammerJNepomGTBinding of outer surface protein A and human lymphocyte function-associated antigen 1 peptides to HLA-DR molecules associated with antibiotic treatment-resistant Lyme arthritisArthritis Rheum20034853454012571864
  • KalishRSWoodJAGoldeWHuman T lymphocyte response to Borrelia burgdorferi infection: no correlation between human leukocyte function antigen type 1 peptide response and clinical statusJ Infect Dis200318710210812508152
  • StrickerRBJohnsonLSearching for autoimmunity in “antibiotic-refractory” Lyme arthritisMol Immunol2008453023302418395260
  • JohnsonLStrickerRBTreatment of Lyme disease: a medicolegal assessmentExpert Rev Anti Infect Ther2004253355715482219
  • RadolfJPosttreatment chronic Lyme disease – what it is notJ Infect Dis200519294894916107945
  • SigalLHHassettALContributions of societal and geographical environments to ‘chronic Lyme disease’: the psychopathogenesis and aporology of a new ‘medically unexplained symptoms’ syndromeEnviron Health Perspect2002110Suppl 460761112194894
  • FederHMJrJohnsonBJO’ConnellSShapiroEDSteereACWormserGPAd Hoc International Lyme Disease Group. A critical appraisal of ‘chronic Lyme disease’N Engl J Med20073571422143017914043
  • KeilpJGCorberaKSlavovITaylorMJSackeimHAFallonBAWAIS-III and WMS-III performance in chronic Lyme diseaseJ Int Neuropsychol Soc20061211912916433951
  • McAuliffePBrassardMRFallonBMemory and executive functions in adolescents with posttreatment Lyme diseaseAppl Neuropsychol20081520821918726742
  • KlempnerMSHuLTEvansJTwo controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme diseaseN Engl J Med2001345859211450676
  • KruppLBHymanLGGrimsonRStudy and treatment of post Lyme disease (STOP-LD): a randomized double masked clinical trialNeurology2003601923193012821734
  • FallonBAKeilpJGCorberaKMA randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathyNeurology200870992100317928580
  • CameronDSeverity of Lyme disease with persistent symptoms: insights from a double blind placebo controlled clinical trialMinerva Med20089948949618971914
  • CameronDJConsequences of treatment delay in Lyme diseaseJ Eval Clin Pract20071347047217518818
  • CameronDJGeneralizability in two clinical trials of Lyme diseaseEpidemiol Perspect Innov20063121817044928
  • Preac-MursicVWeberKPfisterHWSurvival of Borrelia burgdorferi in antibiotically treated patients with Lyme borreliosisInfection1989173553592613324
  • MacDonaldABBergerBWSchwanTGClinical implications of delayed growth of the Lyme borreliosis spirochete, Borrelia burgdorferiActa Trop19904889941980573
  • LiegnerKBShapiroJRRamsayDHalperinAJHogrefeWKongLRecurrent erythema migrans despite extended antibiotic treatment with minocycline in a patient with persisting Borrelia burgdorferi infectionJ Am Acad Dermatol1993282 pt 23123148436647
  • Preac-MursicVPfisterHWSpiegelHFirst isolation of Borrelia burgdorferi from an iris biopsyJ Clin Neuroophthalmol1993131551618106639
  • BattafaranoDFCombsJAEnzenauerRJFitzpatrickJEChronic septic arthritis caused by Borrelia burgdorferiClin Orthop Relat Res19932972382418242938
  • NoctonJJDresslerFRutledgeBJRysPNPersingDHSteereACDetection of Borrelia burgdorferi DNA by polymerase chain reaction in synovial fluid from patients with Lyme arthritisN Engl J Med19943302292348272083
  • BayerMEZhangLBayerMHBorrelia burgdorferi DNA in the urine of treated patients with chronic Lyme disease symptoms: a PCR study of 97 casesInfection1996243473538923044
  • NoctonJJBloomBJRutledgeBJDetection of Borrelia burgdorferi DNA by polymerase chain reaction in cerebrospinal fluid in Lyme neuroborreliosisJ Infect Dis19961746236278769624
  • FreyMJaulhacBPiemontYDetection of Borrelia burgdorferi DNA in muscle of patients with chronic myalgia related to Lyme diseaseAm J Med19981045915949674723
  • OksiJMarjamäkiMNikoskelainenJViljanenMKBorrelia burgdorferi detected by culture and PCR in clinical relapse of disseminated Lyme borreliosisAnn Med19993122523210442678
  • BreierFKhanakahGStanekGIsolation and polymerase chain reaction typing of Borrelia afzelii from a skin lesion in a seronegative patient with generalized ulcerating bullous lichen sclerosus et atrophicusBr J Dermatol200114438739211251580
  • KrausePJSpielmanATelfordSRPersistent parasitemia after acute babesiosisN Engl J Med19983391601659664092
  • AllredDRBabesiosis: persistence in the face of adversityTrends Parasitol200319515512586467
  • VannierEGewurzBEKrausePJHuman babesiosisInfect Dis Clin North Am20082246948818755385
  • HarrusSWanerTAizenbergIFoleyJEPolandAMBarkHAmplification of ehrlichial DNA from dogs 34 months after infection with Ehrlichia canisJ Clin Microbiol19983673769431923
  • StrickerRBMaloneyELAcute infection with human monocytic ehrlichiosis: the tip of the iceberg?South Med J200810121421518364633
  • DumlerJSBakkenJSHuman granulocytic ehrlichiosis in Wisconsin and Minnesota: a frequent infection with the potential for persistenceJ Infect Dis1996173102710308603945
  • GrzeszczukAPuzanowskaBMiegocHProkopowiczDIncidence and prevalence of infection with Anaplasma phagocytophilum: prospective study in healthy individuals exposed to ticksAnn Agric Environ Med20041115515715236514
  • ChomelBBKastenRWSykesJEBoulouisHJBreitschwerdtEBClinical impact of persistent Bartonella bacteremia in humans and animalsAnn N Y Acad Sci200399026727812860639
  • FlorinTAZaoutisTEZaoutisLBBeyond cat scratch disease: widening spectrum of Bartonella henselae infectionPediatrics2008121e1413e142518443019
  • ThomasVAnguitaJBartholdSWFikrigECoinfection with Borrelia burgdorferi and the agent of human granulocytic ehrlichiosis alters murine immune responses, pathogen burden, and severity of Lyme arthritisInfect Immun2001693359337111292759
  • ZeidnerNSDolanMCMassungRPiesmanJFishDCoinfection with Borrelia burgdorferi and the agent of human granulocytic ehrlichiosis suppresses IL-2 and IFN gamma production and promotes an IL-4 response in C3H/HeJ miceParasite Immunol20002258158811116438
  • EskowERaoRVMordechaiEConcurrent infection of the central nervous system by Borrelia burgdorferi and Bartonella henselae: evidence for a novel tick-borne disease complexArch Neurol2001581357136311559306
  • MoroMHZegarra-MoroOLBjornssonJIncreased arthritis severity in mice coinfected with Borrelia burgdorferi and Babesia microtiJ Infect Dis200218642843112134242
  • KrausePJTelfordSR3rdSpielmanAConcurrent Lyme disease and babesiosis. Evidence for increased severity and duration of illnessJAMA1996275165716608637139
  • OlesonCVSivalingamJJO’NeillBJStaasWETransverse myelitis secondary to coexistent Lyme disease and babesiosisJ Spinal Cord Med20032616817112828297
  • KlienebergerEThe natural occurrence of pleuropneumonia like organisms in apparent symbiosis with Streptobacillus moniliformis and other bacteriaJ Pathol Bacteriol19354093105
  • DienesLWeinbergerHJThe L forms of bacteriaBacteriol Rev19511524528814904355
  • DomingueGJWoodyHBBacterial persistence and expression of diseaseClin Microbiol Rev1997103203449105757
  • MargulisLJAshenBSoleMGuerreroRComposite, large spirochetes from microbial mats: spirochete structure reviewProc Natl Acad Sci U S A199390696669708346204
  • Preac MursicVWannerGReinhardtSBuschUMargetWFormation and cultivation of Borrelia burgdorferi spheroplast-L-form variantsInfection1996242182268811359
  • BrorsonØBrorsonSHTransformation of cystic forms of Borrelia burgdorferi to normal mobile spirochetesInfection1997252402469266264
  • BrorsonØBrorsonSHIn vitro conversion of Borrelia burgdorferi to cystic forms in spinal fluid, and transformation to mobile spirochetes by incubation in BSK-H mediumInfection1998261441509646104
  • GruntarIMalovrhTMurgiaRCincoMConversion of Borrelia garinii cystic forms to motile spirochetes in vivoAPMIS200110938338811478686
  • MurgiaRCincoMInduction of cystic forms by different stress conditions in Borrelia burgdorferiAPMIS2004112576214961976
  • de OliveiraAFonsecaAHda CostaCMMantovaniEYoshinariNHGrowth, cysts and kinetics of Borrelia garinii (Spirochaetales: Spirochaetacea) in different culture mediaMem Inst Oswaldo Cruz201010571771920835623
  • MiklossyJKhaliliKGernLBorrelia burgdorferi persists in the brain in chronic Lyme neuroborreliosis and may be associated with Alzheimer diseaseJ Alzheimers Dis2004663964915665404
  • MacDonaldABPlaques of Alzheimer’s disease originate from cysts of Borrelia burgdorferi, the Lyme disease spirocheteMed Hypotheses20066759260016675154
  • MiklossyJKasasSZurnADMcCallSYuSMcGeerPLPersisting atypical and cystic forms of Borrelia burgdorferi and local inflammation in Lyme neuroborreliosisJ Neuroinflammation200854018817547
  • BrorsonØBrorsonSHAn in vitro study of the susceptibility of mobile and cystic forms of Borrelia burgdorferi to metronidazoleAPMIS199910756657610379684
  • BrorsonØBrorsonSHAn in vitro study of the susceptibility of mobile and cystic forms of Borrelia burgdorferi to tinidazoleInt Microbol20047139142
  • BrorsonØBrorsonSHAn in vitro study of the activity of telithromycin against mobile and cystic forms of Borrelia afzeliiInfection200634262816501899
  • BrorsonØBrorsonSHScythesJMacAllisterJWierAMargulisLDestruction of spirochete Borrelia burgdorferi round-body propagules (RBs) by the antibiotic tigecyclineProc Natl Acad Sci U S A2009106186561866119843691
  • GloverWAYangYZhangYInsights into the molecular basis of L-form formation and survival in Escherichia coliPLoS One20094e731619806199
  • DaveyMEO’TooleGAMicrobial biofilms: from ecology to molecular geneticsMicrobiol Mol Biol Rev20006484786711104821
  • StoodleyPSauerKDaviesDGCostertonJWBiofilms as complex differentiated communitiesAnnu Rev Microbiol20025618720912142477
  • HoaMSyamalMSchaefferMASachdevaLBerkRCoticchiaJBiofilms and chronic otitis media: an initial exploration into the role of biofilms in the pathogenesis of chronic otitis mediaAm J Otolaryngol20103124124520015753
  • TrautnerBWDarouicheRORole of biofilm in catheter-associated urinary tract infectionAm J Infect Control20043217718315153930
  • de PazLEBergenholtzGSvensäterGThe effects of antimicrobials on endodontic biofilm bacteriaJ Endod201036707720003938
  • HamiltonSBongaertsRJMulhollandFThe transcriptional programme of Salmonella enterica serovar Typhimurium reveals a key role for tryptophan metabolism in biofilmsBMC Genomics20091059920003355
  • RamageGMowatEJonesBWilliamsCLopez-RibotJOur current understanding of fungal biofilmsCrit Rev Microbiol20093534035519863383
  • SapiEMacDonaldABiofilms of Borrelia burgdorferi in chronic cutaneous borreliosisAm J Clin Pathol2008129988989
  • Dunham-EmsSMCaimanoMJPalULive imaging reveals a biphasic mode of dissemination of Borrelia burgdorferi within ticksJ Clin Invest20091193652366519920352
  • EisendleKMüllerHZelgerBBiofilms of Borrelia burgdorferi in chronic cutaneous borreliosisAm J Clin Pathol2008129989990
  • RyjenkovDATarutinaMMoskvinOVGomelskyMCyclic diguanylate is a ubiquitous signaling molecule in bacteria: insights into biochemistry of the GGDEF protein domainJ Bacteriol20051871792179815716451
  • CotterPAStibitzSc-di-GMP-mediated regulation of virulence and biofilm formationCurr Opin Microbiol200710172317208514
  • RogersEATerekhovaDZhangHMHovisKMSchwartzIMarconiRTRrp1, a cyclic-di-GMP-producing response regulator, is an important regulator of Borrelia burgdorferi core cellular functionsMol Microbiol2009711551157319210621
  • FreedmanJCRogersEAKostickJLIdentification and molecular characterization of a cyclic-di-GMP effector protein, PlzA (BB0733): additional evidence for the existence of a functional cyclic-di-GMP regulatory network in the Lyme disease spirochete, Borrelia burgdorferiFEMS Immunol Med Microbiol20105828529420030712
  • SauerKThe genomics and proteomics of biofilm formationGenome Biol2003421912801407
  • PetrovaOESauerKA novel signaling network essential for regulating Pseudomonas aeruginosa biofilm developmentPLoS Pathog20095e100066819936057
  • RichardsJJMelanderCControlling bacterial biofilmsChembiochem2009102287229419681090
  • RogersSAHuigensRW3rdCavanaghJMelanderCSynergistic effects between conventional antibiotics and 2-aminoimidazole-derived antibiofilm agentsAntimicrob Agents Chemother2010542112211820211901
  • StrickerRBJohnsonLLyme wars: let’s tackle the testingBMJ2007335100818006976
  • TiltonRCSandMNManakMThe Western immunoblot for Lyme disease: determination of sensitivity, specificity, and interpretive criteria with use of commercially available performance panelsClin Infect Dis199725Suppl 1S31S349233661
  • BinnickerMJJespersenDJHarringJARollinsLOBryantSCBeitoEMEvaluation of two commercial systems for the automated processing, reading and interpretation of Lyme Western blotsJ Clin Microbiol2008462216222118463211
  • SantinoIBerluttiFPantanellaFSessaRdel PianoMDetection of Borrelia burgdorferi sensu lato DNA by PCR in serum of patients with clinical symptoms of Lyme borreliosisFEMS Microbiol Lett2008283303518384365
  • StrickerRBJohnsonLLyme disease debate: facts or fiction BMJ Rapid Response. Available from: http://www.bmj.com/content/335/7628/1008.1.full/reply-bmj_el_194233. Accessed Nov 8 2010.
  • StrickerRBIDSA hearing presentation: Problems with diagnosis and treatment of Lyme disease Available from: http://www.ilads.org/lyme_disease/media/lyme_video_stricker.html. Accessed Nov 8 2010.
  • StrickerRBJohnsonLGender bias in chronic lyme diseaseJ Womens Health (Larchmt)2009181717171819857097
  • SillanpääHLahdennePSarvasHImmune responses to borrelial VlsE IR6 peptide variantsInt J Med Microbiol2007297455217234451
  • Gomes-SoleckiMJMeirellesLGlassJDattwylerRJEpitope length, genospecies dependency, and serum panel effect in the IR6 enzyme-linked immunosorbent assay for detection of antibodies to Borrelia burgdorferiClin Vaccine Immunol20071487587917538122
  • CrowderCDMatthewsHESchutzerSGenotypic variation and mixtures of Lyme Borrelia in Ixodes ticks from North America and EuropePLoS One20105e1065020498837
  • EshooMWCrowderCDLiHDetection and identification of Ehrlichia species in blood by use of PCR and electrospray ionization mass spectrometryJ Clin Microbiol20104847247819955274
  • StrickerRBWingerEEDecreased CD57 lymphocyte subset in patients with chronic Lyme diseaseImmunol Lett200176434811222912
  • StrickerRBBurrascanoJWingerEELongterm decrease in the CD57 lymphocyte subset in a patient with chronic Lyme diseaseAnn Agric Environ Med2002911111312088407
  • StrickerRBWingerEENatural killer cells in chronic Lyme diseaseClin Vaccine Immunol200916170419880717
  • ShoemakerRCGiclasPCCrowderCHouseDGlovskyMMComplement split products C3a and C4a are early markers of acute Lyme disease in tick bite patients in the United StatesInt Arch Allergy Immunol200814625526118270493
  • StrickerRBSavelyVRMotanyaNCGiclasPCComplement split products C3a and C4a in chronic Lyme diseaseScand J Immunol200969646919140878
  • BarbourAGJasinskasAKayalaMAA genome-wide proteome array reveals a limited set of immunogens in natural infections of humans and white-footed mice with Borrelia burgdorferiInfect Immun2008763374338918474646
  • XuYBrunoJFLuftBJProfiling the humoral immune response to Borrelia burgdorferi infection with protein microarraysMicrob Pathog20084540340718976702
  • MontagnierLAïssaJFerrisSMontagnierJLLavalléeCElectromagnetic signals are produced by aqueous nanostructures derived from bacterial DNA sequencesInterdiscip Sci20091819020640822
  • MontagnierLAïssaJLavalléeCMbamyMVaronJChenalHElectromagnetic detection of HIV DNA in the blood of AIDS patients treated by antiretroviral therapyInterdiscip Sci2009124525320640802
  • GriffinMTAIDS drugs and the pharmaceutical industry: a need for reformAm J Law Med1991173634101812767
  • StrickerRBJohnsonLLyme disease diagnosis and treatment: lessons from the AIDS epidemicMinerva Med201010141942521196901
  • LawsonKTreatment options and patient perspectives in the management of fibromyalgia: future trendsNeuropsychiatr Dis Treat200841059107119337451
  • StrickerRBCounterpoint: long-term antibiotic therapy improves persistent symptoms associated with Lyme diseaseClin Infect Dis20074514915717578772
  • StrickerRBJohnsonLChronic Lyme disease and the ‘Axis of Evil’Future Microbiol2008362162419072179